LANADELUMAB for Immunodeficiency common variable: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 5 adverse event reports in the FDA FAERS database where LANADELUMAB was used for Immunodeficiency common variable.
Most Reported Side Effects for LANADELUMAB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Hereditary angioedema | 1,343 | 65.3% | 41 | 728 |
| Product dose omission issue | 555 | 27.0% | 15 | 307 |
| Weight decreased | 361 | 17.5% | 9 | 238 |
| Weight increased | 353 | 17.2% | 9 | 225 |
| Inappropriate schedule of product administration | 318 | 15.5% | 11 | 171 |
| Product use issue | 229 | 11.1% | 3 | 129 |
| Covid-19 | 225 | 10.9% | 9 | 127 |
| Injection site pain | 201 | 9.8% | 7 | 94 |
| Insurance issue | 172 | 8.4% | 2 | 98 |
| Drug ineffective | 142 | 6.9% | 4 | 77 |
| Stress | 137 | 6.7% | 0 | 73 |
| Headache | 121 | 5.9% | 1 | 62 |
| Fall | 119 | 5.8% | 6 | 82 |
| Pneumonia | 112 | 5.4% | 8 | 75 |
| Illness | 107 | 5.2% | 5 | 59 |
Other Indications for LANADELUMAB
Immune system disorder (1,047)
Hereditary angioedema (1,012)
Product used for unknown indication (179)
Prophylaxis (151)
Hereditary angioedema with c1 esterase inhibitor deficiency (73)
Angioedema (33)
Hereditary angioedema with normal c1 esterase inhibitor (32)
Idiopathic urticaria (11)
Asthma (9)
Idiopathic angioedema (6)
Other Drugs Used for Immunodeficiency common variable
HUMAN IMMUNOGLOBULIN G (17,389)
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN (1,598)
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE (881)
GAMMAGARD LIQUID (81)
HIZENTRA (76)
DUPILUMAB (69)
RITUXIMAB (44)
INFLIXIMAB (28)
PREDNISOLONE (27)
HUMAN C1-ESTERASE INHIBITOR (24)